Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

First data on once-weekly DPP IV inhibitor MK-3102 reported

Oct. 4, 2012

Sanofi patents new 11-beta-HSD1 inhibitors

Oct. 4, 2012

Ipragliflozin has beneficial effects in Japanese patients with type 2 diabetes

Oct. 4, 2012

Japanese approval granted for Buphenyl for urea cycle disorders

Oct. 3, 2012

Eliglustat tartrate meets primary endpoint in phase III trial in Gaucher's disease

Oct. 3, 2012

Novo Nordisk's insulin degludec obtains first approval

Oct. 2, 2012

Shionogi and Kotobuki Pharmaceutical sign license agreement for cholesterol absorption inhibitor

Oct. 2, 2012

Bayer HealthCare joins forces with Evotec on endometriosis

Oct. 2, 2012

Suini approved in Japan for type 2 diabetes

Oct. 2, 2012

Novel AMPK activators synthesized at GlaxoSmithKline

Oct. 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...